There is a variety of studies that IL-33 originally known as a Th2-dominant cytokine performs a beneficial role in the treatment of situations such as transplantation, obesity, and cardiovascular diseases [16, 24, 25]. This evidence concerns the gene IL33 and obesity disorder.